FDA mulls relaxing rules for unproven peptide therapies championed by RFK Jr.
TL;DR Summary
The FDA is weighing loosening restrictions on certain peptide therapies promoted by RFK Jr., which could expand access to unproven treatments while sparking concerns about safety, efficacy, and how such therapies are marketed.
Reading Insights
Total Reads
0
Unique Readers
20
Time Saved
16 min
vs 17 min read
Condensed
99%
3,276 → 33 words
Want the full story? Read the original article
Read on AP News